Mechanisms of Cardiac Fibrosis in Inflammatory Heart Disease

被引:169
|
作者
Kania, Gabriela [2 ]
Blyszczuk, Przemyslaw [2 ]
Eriksson, Urs [1 ]
机构
[1] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Inst Physiol, Dept Cardiovasc Res, CH-8057 Zurich, Switzerland
关键词
EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; MARROW-DERIVED CELLS; HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR; ENTEROVIRUS MYOCARDITIS; MAST-CELLS; TGF-BETA; MYOFIBROBLASTS; CARDIOMYOPATHY; PATHOGENESIS;
D O I
10.1016/j.tcm.2010.02.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart injury from many causes can end up in a common final pathway of pathologic remodeling and fibrosis, promoting heart failure development. Dilated cardiomyopathy is an important cause of heart failure and often results from virus-triggered myocarditis. Monocytes and monocyte-like cells represent a major subset of heart-infiltrating cells at the injury site. These bone marrow-derived cells promote not only tissue injury in the short term but also angiogenesis and collagen deposition in the long term. Thus, they are critically involved in the typical tissue fibrosis, which evolves in the dilating ventricle during the process of pathologic remodeling. Recent findings suggest that heart-infiltrating monocyte-like cells indeed contain a pool of progenitors, which represent the cellular source both for accumulation of differentiated monocytes during the acute inflammatory phase and for transforming growth factor-beta-mediated myocardial fibrosis during the later chronic stages of disease. Obviously, a delicate balance of proinflammatory and pro fibrotic cytokines dictates the fate of bone marrow-derived heart-infiltrating progenitors and directly influences the morphologic phenotype of the affected heart. In this minireview, we provide an update on these mechanisms and discuss their significance in pathologic remodeling and heart failure progression after myocarditis. (Trends Cardiovasc Med 2009;19:247-252) (C) 2009, Elsevier Inc.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [1] Cardiac fibrosis in the ageing heart: Contributors and mechanisms
    Lu, Lu
    Guo, Jingbin
    Hua, Yue
    Huang, Kevin
    Magaye, Ruth
    Cornell, Jake
    Kelly, Darren J.
    Reid, Christopher
    Liew, Danny
    Zhou, Yingchun
    Chen, Aihua
    Xiao, Wei
    Fu, Qiang
    Wang, Bing Hui
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 : 55 - 63
  • [2] Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease
    Frohlich, ED
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (06) : 693 - 700
  • [3] Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease
    Weber, Karl T.
    Sun, Yao
    Gerling, Ivan C.
    Guntaka, Ramareddy V.
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (11) : 1049 - 1052
  • [4] Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts
    Weber, KT
    JOURNAL OF HYPERTENSION, 2004, 22 (01) : 47 - 50
  • [6] Is disrupting cardiac fibrosis a rational strategy for treating heart disease?
    Hara, Akitoshi
    Tallquist, Michelle D.
    NATURE CARDIOVASCULAR RESEARCH, 2022, 1 (05): : 405 - 407
  • [7] Is disrupting cardiac fibrosis a rational strategy for treating heart disease?
    Akitoshi Hara
    Michelle D. Tallquist
    Nature Cardiovascular Research, 2022, 1 : 405 - 407
  • [8] Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
    Fan, Dong
    Takawale, Abhijit
    Lee, Jiwon
    Kassiri, Zamaneh
    FIBROGENESIS & TISSUE REPAIR, 2012, 5
  • [9] Mechanisms of Disease Proteotoxicity and Cardiac Dysfunction - Alzheimer's Disease of the Heart?
    Willis, Monte S.
    Patterson, Cam
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (05): : 455 - 464
  • [10] β-adrenergic signaling in the heart -: novel insights about mechanisms of cardiac hypertrophy and fibrosis
    Engelhardt, S
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 314 - 315